| VX-445–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles D Keating, G Marigowda, L Burr, C Daines, MA Mall, EF McKone, ... New england journal of medicine 379 (17), 1612-1620, 2018 | 657 | 2018 |
| A novel microbiota stratification system predicts future exacerbations in bronchiectasis GB Rogers, NMM Zain, KD Bruce, LD Burr, AC Chen, DW Rivett, ... Annals of the American Thoracic Society 11 (4), 496-503, 2014 | 237 | 2014 |
| The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo … GB Rogers, KD Bruce, ML Martin, LD Burr, DJ Serisier The lancet Respiratory medicine 2 (12), 988-996, 2014 | 195 | 2014 |
| Matrix metalloproteinases vary with airway microbiota composition and lung function in non–cystic fibrosis bronchiectasis SL Taylor, GB Rogers, ACH Chen, LD Burr, MA McGuckin, DJ Serisier Annals of the American Thoracic Society 12 (5), 701-707, 2015 | 102 | 2015 |
| Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis KA Ramsey, ACH Chen, G Radicioni, R Lourie, M Martin, A Broomfield, ... American journal of respiratory and critical care medicine 201 (6), 661-670, 2020 | 92 | 2020 |
| Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease C Rigauts, J Aizawa, SL Taylor, GB Rogers, M Govaerts, P Cos, L Ostyn, ... European Respiratory Journal 59 (5), 2022 | 87 | 2022 |
| Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry SK Visser, PTP Bye, GJ Fox, LD Burr, AB Chang, CL Holmes-Liew, P King, ... Respiratory medicine 155, 97-103, 2019 | 71 | 2019 |
| Oxidative and endoplasmic reticulum stress in respiratory disease ACH Chen, L Burr, MA McGuckin Clinical & translational immunology 7 (6), e1019, 2018 | 71 | 2018 |
| Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut Y Wang, LEX Leong, RL Keating, T Kanno, GCJ Abell, FM Mobegi, ... Gut Microbes 10 (3), 367-381, 2019 | 54 | 2019 |
| The impact of CFTR modulator therapies on CF airway microbiology GB Rogers, SL Taylor, LR Hoffman, LD Burr Journal of Cystic Fibrosis 19 (3), 359-364, 2020 | 50 | 2020 |
| Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce JP Vogel, B Tendal, M Giles, C Whitehead, W Burton, S Chakraborty, ... Australian and New Zealand Journal of Obstetrics and Gynaecology 60 (6), 840-851, 2020 | 46 | 2020 |
| FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis SL Taylor, RJ Woodman, ACH Chen, LD Burr, DL Gordon, MA McGuckin, ... Thorax 72 (4), 304-310, 2017 | 42 | 2017 |
| Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non–Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low … LD Burr, GB Rogers, ACH Chen, BR Hamilton, GF Pool, SL Taylor, ... Annals of the American Thoracic Society 13 (10), 1697-1703, 2016 | 42 | 2016 |
| Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma RB Werder, MA Ullah, MM Rahman, J Simpson, JP Lynch, N Collinson, ... American Journal of Respiratory and Critical Care Medicine 205 (3), 300-312, 2022 | 39 | 2022 |
| Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis JM Choo, GCJ Abell, R Thomson, L Morgan, G Waterer, DL Gordon, ... Msphere 3 (2), 10.1128/msphere. 00103-18, 2018 | 37 | 2018 |
| Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation ACH Chen, ML Martin, R Lourie, GB Rogers, LD Burr, SZ Hasnain, ... PLoS One 10 (3), e0119325, 2015 | 28 | 2015 |
| Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials AZ Uluer, G MacGregor, P Azevedo, V Indihar, C Keating, MA Mall, ... The Lancet Respiratory Medicine 11 (6), 550-562, 2023 | 23 | 2023 |
| GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection CX Foo, S Bartlett, KY Chew, MD Ngo, H Bielefeldt-Ohmann, ... European Respiratory Journal 61 (3), 2023 | 20 | 2023 |
| Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven? SK Visser, PTP Bye, GJ Fox, LD Burr, AB Chang, CL Holmes-Liew, P King, ... Lung 197, 803-810, 2019 | 18 | 2019 |
| Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy SL Taylor, LEX Leong, FM Mobegi, JM Choo, LD Burr, S Wesselingh, ... Multidisciplinary respiratory medicine 13, 9-14, 2018 | 18 | 2018 |
